M Ewertz

Summary

Affiliation: Aalborg Hospital
Country: Denmark

Publications

  1. pmc Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort study
    M Ewertz
    Department of Oncology, Aalborg Hospital, Aarhus University, Hobrovej 18 22, PO Box 365, DK 9100 Aalborg, Denmark
    Br J Cancer 92:1293-7. 2005
  2. pmc Use of postmenopausal hormone replacement therapy and risk of non-Hodgkin's lymphoma: a Danish population-based cohort study
    M Nørgaard
    Department of Clinical Epidemiology, Aarhus University Hospital, Sdr Skovvej 15, Postbox 365, DK 9100 Aalborg, Denmark
    Br J Cancer 94:1339-41. 2006
  3. ncbi Risk of docetaxel-induced peripheral neuropathy among 1,725 Danish patients with early stage breast cancer
    L Eckhoff
    Department of Oncology, Odense University Hospital, Sdr Boulevard 29, 5000, Odense, Denmark
    Breast Cancer Res Treat 142:109-18. 2013
  4. pmc Influence of comorbidity on the effect of adjuvant treatment and age in patients with early-stage breast cancer
    L H Land
    Department of Oncology, Odense University Hospital, Sdr Boulevard 29, Odense C 5000, Denmark
    Br J Cancer 107:1901-7. 2012
  5. doi PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab
    J D Jensen
    Department of Oncology, Odense University Hospital, and Institute of Clinical Research, University of Southern Denmark, Odense, Denmark
    Ann Oncol 23:2034-42. 2012
  6. doi MRI and PET/CT of patients with bone metastases from breast carcinoma
    J Grankvist
    Department of Radiology, Aalborg Hospital, Hobrovej 18 22, 9000 Aalborg, Denmark
    Eur J Radiol 81:e13-8. 2012
  7. ncbi Breast cancer in Denmark. Incidence, risk factors, and characteristics of survival
    M Ewertz
    Danish Cancer Society, Division for Cancer Epidemiology, Copenhagen
    Acta Oncol 32:595-615. 1993
  8. ncbi Risk factors for breast cancer and their prognostic significance
    M Ewertz
    Danish Cancer Registry, Institute of Cancer Epidemiology under the Danish Cancer Society, Copenhagen, Denmark
    Acta Oncol 27:733-7. 1988
  9. pmc Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram
    T L Lash
    Department of Epidemiology, Boston University School of Public Health, 715 Albany Street, Boston, MA 02118, USA
    Br J Cancer 99:616-21. 2008
  10. pmc Comorbidity and survival of Danish breast cancer patients from 1995 to 2005
    D P Cronin-Fenton
    Department of Clinical Epidemiology, Aarhus University Hospital, Ole Worms Alle 1150, Aarhus C 8000, Denmark
    Br J Cancer 96:1462-8. 2007

Detail Information

Publications16

  1. pmc Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort study
    M Ewertz
    Department of Oncology, Aalborg Hospital, Aarhus University, Hobrovej 18 22, PO Box 365, DK 9100 Aalborg, Denmark
    Br J Cancer 92:1293-7. 2005
    ..No material risk difference was observed among the various HRT-regimens. This population-based cohort study provides further confirmation that HRT increases the risk of developing breast cancer in women aged 50 years or more...
  2. pmc Use of postmenopausal hormone replacement therapy and risk of non-Hodgkin's lymphoma: a Danish population-based cohort study
    M Nørgaard
    Department of Clinical Epidemiology, Aarhus University Hospital, Sdr Skovvej 15, Postbox 365, DK 9100 Aalborg, Denmark
    Br J Cancer 94:1339-41. 2006
    ..7 per 100,000 among HRT users and 24.2 per 100,000 among non-users, yielding an adjusted RR of 0.99 (95% CI: 0.71-1.39). Our data did not support an association between HRT use and risk of NHL...
  3. ncbi Risk of docetaxel-induced peripheral neuropathy among 1,725 Danish patients with early stage breast cancer
    L Eckhoff
    Department of Oncology, Odense University Hospital, Sdr Boulevard 29, 5000, Odense, Denmark
    Breast Cancer Res Treat 142:109-18. 2013
    ..56; 95 % CI 0.38-0.81) in the EPN group. Patients developing PN after the first cycle are less likely to receive docetaxel at the planned dose intensity and usage of frozen gloves and socks may modify the risk...
  4. pmc Influence of comorbidity on the effect of adjuvant treatment and age in patients with early-stage breast cancer
    L H Land
    Department of Oncology, Odense University Hospital, Sdr Boulevard 29, Odense C 5000, Denmark
    Br J Cancer 107:1901-7. 2012
    ..The aim of this study was to examine the effect of breast cancer treatment on mortality, taking age at diagnosis and comorbidity into account...
  5. doi PIK3CA mutations, PTEN, and pHER2 expression and impact on outcome in HER2-positive early-stage breast cancer patients treated with adjuvant chemotherapy and trastuzumab
    J D Jensen
    Department of Oncology, Odense University Hospital, and Institute of Clinical Research, University of Southern Denmark, Odense, Denmark
    Ann Oncol 23:2034-42. 2012
    ....
  6. doi MRI and PET/CT of patients with bone metastases from breast carcinoma
    J Grankvist
    Department of Radiology, Aalborg Hospital, Hobrovej 18 22, 9000 Aalborg, Denmark
    Eur J Radiol 81:e13-8. 2012
    ..In conclusion, 3.0Tesla MRI with T1, STIR, and DWI is useful for the clinical evaluation of bone metastases from breast cancer and compares well to PET/CT...
  7. ncbi Breast cancer in Denmark. Incidence, risk factors, and characteristics of survival
    M Ewertz
    Danish Cancer Society, Division for Cancer Epidemiology, Copenhagen
    Acta Oncol 32:595-615. 1993
    ..There was no relation between survival and reproductive or hormonal factors, dietary variables, alcohol consumption, or smoking. However, a complex relationship may exist between survival and body mass index...
  8. ncbi Risk factors for breast cancer and their prognostic significance
    M Ewertz
    Danish Cancer Registry, Institute of Cancer Epidemiology under the Danish Cancer Society, Copenhagen, Denmark
    Acta Oncol 27:733-7. 1988
    ..Classical risk factors, such as high social status, nulliparity, early menarche and late natural menopause were confirmed, while no association was found between breast cancer and maternal age at first childbirth...
  9. pmc Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram
    T L Lash
    Department of Epidemiology, Boston University School of Public Health, 715 Albany Street, Boston, MA 02118, USA
    Br J Cancer 99:616-21. 2008
    ..These results suggest that concurrent use of citalopram does not reduce tamoxifen's prevention of breast cancer recurrence...
  10. pmc Comorbidity and survival of Danish breast cancer patients from 1995 to 2005
    D P Cronin-Fenton
    Department of Clinical Epidemiology, Aarhus University Hospital, Ole Worms Alle 1150, Aarhus C 8000, Denmark
    Br J Cancer 96:1462-8. 2007
    ..Such poorer survival is an important public health concern and can be expected to worsen as the population ages...
  11. pmc Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG)
    S Cold
    Oncology Department R, Odense University Hospital, Sdr Boulevard 29, DK 5000 Odense C, Denmark
    Br J Cancer 93:627-32. 2005
    ..In conclusion, we have found no evidence for a survival benefit due to early initiation of adjuvant chemotherapy within the first 2-3 months after surgery...
  12. ncbi Time trends and regional differences in registration, stage distribution, surgical management and survival of breast cancer in Denmark
    A R Jensena
    Department of Experimental Clinical Oncology, Danish Cancer Society, Aarhus University Hospital, Norrebrogade 44, Building 5, DK 8000 Aarhus C, Denmark
    Eur J Cancer 39:1783-93. 2003
    ..The DBCG database cannot be considered as representative of the Danish population of breast cancer patients...
  13. pmc Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease
    N Hamajima
    Cancer Research UK Epidemiology Unit, Gibson Building, Radcliffe Infirmary, Woodstock Road, Oxford OX2 6HE, UK
    Br J Cancer 87:1234-45. 2002
    ....
  14. ncbi Risk factors for male breast cancer--a case-control study from Scandinavia
    M Ewertz
    Danish Cancer Society, Division for Cancer Epidemiology, Copenhagen, Denmark
    Acta Oncol 40:467-71. 2001
    ..Several patients died before contact. Thus, risk factors related to a more aggressive male breast cancer or related to high risk of dying (e.g. liver cirrhosis, heavy smoking) may have been missed...
  15. ncbi Risk of breast cancer in relation to social factors in Denmark
    M Ewertz
    Danish Cancer Society, Institute of Cancer Epidemiology, Copenhagen, Denmark
    Acta Oncol 27:787-92. 1988
    ..Women working in offices had an increased RR while no other occupation was significantly associated with breast cancer. Social or occupational factors did not explain the urban/rural difference in risk seen in this study...
  16. ncbi The association between risk of breast cancer and age at first pregnancy and parity in Maribo County, Denmark
    A Mellemgaard
    Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen
    Acta Oncol 29:705-8. 1990
    ..85 vs 1.20). In subgroups of women defined by parity the relative risk decreased with increasing number of pregnancies from about unity among women with 0-3 pregnancies to 0.7 among women with 6 or more pregnancies...